ISSN 1662-4009 (online)

Previous issue | Volume 19 | ESPEYB19 | Next issue

Yearbook of Paediatric Endocrinology 2022

8. Adrenals

Reviews

ey0019.8-13 | Reviews | ESPEYB19

8.13. Diagnosis and treatment of primary aldosteronism

M Reincke , I Bancos , P Mulatero , UI Scholl , M Stowasser , TA Williams

Lancet Diabetes Endocrinol. 2021; 9(12):876-892. PMID: 34798068https://pubmed.ncbi.nlm.nih.gov/34798068/Brief Summary: This review summarizes the current knowledge on the epidemiology, genetic background, pathophysiology, clinical presentation, diagnosis and treatment of primary aldosteronism.This review article on primary aldosteronism (PA) describes its clinical char...

ey0019.8-14 | Reviews | ESPEYB19

8.14. Should Dehydroepiandrosterone be administered to women?

ME Wierman , K Kiseljak-Vassiliades

J Clin Endocrinol Metab. 2022; 107(6): 1679-1685. PMID: 35254428https://pubmed.ncbi.nlm.nih.gov/35254428/Brief Summary: This review summarizes the evidence on the potential benefits and risks of androgen prohormones, such as dehydroepiandrosterone (DHEA), in normal women and those with DHEA-deficient states.Physiologically, the concentrations of DHEA and DHEAS increase...

ey0019.8-15 | Reviews | ESPEYB19

8.15. The genetics of autoimmune Addison disease: past, present and future

C Ellen , EC Royrvik , ES Husebye

Nat Rev Endocrinol. 2022; 18(7): 399-412. PMID: 35411072https://pubmed.ncbi.nlm.nih.gov/35411072/Brief Summary: This review summarizes the current knowledge and understanding of the genetics of autoimmune Addison disease and its position in the wider field of autoimmune disorders.Autoimmune AddisonÂ’s disease (AAD) is caused by the destruction of the adrenal cortex...

ey0019.8-16 | Reviews | ESPEYB19

8.16. Management challenges and therapeutic advances in congenital adrenal hyperplasia

A Mallappa , DP Merke

Nat Rev Endocrinol. 2022; 18(6): 337-352. PMID: 35411073https://pubmed.ncbi.nlm.nih.gov/35411073/Brief Summary: This review summarizes the current knowledge and understanding of the therapeutic challenges and the novel advances in the management of classical congenital adrenal hyperplasia (CAH).This review describes the present and novel therapeutic options for 21OHD C...